{
    "nctId": "NCT02827370",
    "briefTitle": "CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer",
    "officialTitle": "CAREFOR Study: Precision Nutrition Caloric Restriction for Oncology Research: Precision Medicine Driving Precision Nutrition During Neoadjuvant Chemotherapy for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 26,
    "primaryOutcomeMeasure": "Pathologic complete response assessed in tissue",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Pathologically proven invasive breast cancer\n* Planned neoadjuvant chemotherapy determined by the judgment of the medical oncologist\n* The patient must be female\n* Age \u2265 18\n* Non-metastatic and non-inflammatory breast cancer\n* History/physical examination, including breast exam and documentation of weight and Karnofsky Performance Status of 80-100% for at least 60 days prior to study entry.\n* Women of childbearing potential must be non-pregnant and non-lactating and willing to use medically acceptable form of contraception during chemotherapy\n* Patient must capable of and provide study specific informed consent prior to study entry\n* BMI \u226521\n* Weight \u2265120lbs\n* No prior history of non-breast malignancies in the past 1 year unless it was a non- melanomatous skin lesion or carcinoma in situ of the cervix.\n* Patient must not have Acquired Immune Deficiency Syndrome (AIDS) or HIV positive based upon current CDC definition; note, however, that HIV testing is not required for entry into this protocol. The need to exclude patients with AIDS or HIV from this protocol is necessary because anti-retrovirals may alter patient metabolism.\n* Patient may not have any active Gastrointestinal/Malabsorption disorder at the discretion of the Principal Investigator which may include:\n* Chronic Pancreatitis\n* Chronic Diarrhea or Vomiting\n* Active Eating Disorder\n* No history of or current active drug/alcohol dependence.\n* No patients with decisional impairment.\n\nExclusion Criteria:\n\n* Patient is male.\n* Age \\<18 years\n* Clinical stage IV cancer\n* Inflammatory breast cancer (T4d)\n* Women of childbearing potential with a positive serum beta hCG.\n* Decision impaired patients.\n* BMI \\< 21\n* Weight \\< 120lbs\n* Weight loss \u226510% in the last 3 mos\n* Prior invasive non-breast malignancy (except non-melanomatous skin cancer, carcinoma in situ of the cervix) unless disease free for a minimum of 1 year prior to registration\n* Non-epithelial breast malignancies such as sarcoma or lymphoma\n* Active Gastrointestinal/Malabsorption disorder at the discretion of the Principal -Investigator which may include:\n\n  * Chronic Diarrhea or Vomiting\n  * Active Eating Disorder\n  * Active drug/alcohol dependence or abuse history.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}